Investigation of the metabolism of C-14-bunazosin (2.0mg) in 3 healthy
male volunteers indicated that the primary route of metabolism of thi
s alpha1-adrenoceptor antagonist, as for other quinazoline derivatives
, is via demethylation and hydroxylation. Of the total radioactivity a
dministered, 37% was recovered in the urine and 58% in the faeces over
the 7-day period postdose. Urinary radioactivity was accounted for by
metabolites (96%). predominantly bunazosin-N-glucuronide and unidenti
fied polar compounds, and a small amount of unchanged bunazosin (4%).
Faecal radioactivity was due to unchanged bunazosin (11%) and a variet
y of metabolites, including 6- and 7-desmethylbunazosin and unidentifi
ed polar compounds. O-glucuronides were present in similar amounts in
the urine and faeces, whereas N-glucuronides were more abundant in the
urine.